Table 1 Demographic, clinical and biochemical characteristics of study patients

Age (years)

52.68 + 16.33

Sex (M/F)

17/14

ESRD duration (months)

48.5 + 22.1

Duration of APD (months)

30.34 + 17.65

DM (%)

41.9

HTN (%)

67.7

Smoking (%)

29.0

History of ischemic cardiac disease (n, %)

5 (16.1)

BMI (kg/m²)

23.75 + 5.11

Residual urine (l/day)

0.8 + 0.3

Hemoglobin (g/dl)

8.8 + 1.4

CRP (mg/dl)

1.29 + 0.51

Albumin (g/dl)

3.21 + 0.32

Calcium (mg/dl)

8.22 + 0.95

Phosphorus

4.88 + 1.31

PTH (pg/ml)

377.6 + 174.8

TC (mg/dl)

284.9 + 46.5

TG (mg/dl)

252.3 + 33.6

LD-C (mg/dl)

169.5 + 44.8

BUN (mg/dl)

78.5 + 7.32

Kt/V, median (IQR)

1.72 (1.54-1.86)

Darbepoetin dose, median (IQR)

60 (40-80)